13.07.2015 Views

Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare (2008) - The Black Vault

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Medical</strong> Management <strong>of</strong> <strong>Chemical</strong> Toxicity in PediatricsTable 21-2Mark I* Kit Dosing for Children with Severe, Life-threatening Nerve Agent Toxicity †Approximate Age Approximate Number <strong>of</strong> Kits Atropine Dosage Range Pralidoxime Dosage Range(in years) Weight to Use (mg/kg) (mg/kg)3–7 13–25 kg 1 0.08–0.13 24–468–14 26–50 kg 2 0.08–0.13 24–46> 14 > 51 kg 3 0.11 or less 35 or less*Meridian <strong>Medical</strong> Technologies Inc, Bristol, Tenn.† If an adult Mark I kit is the only available source <strong>of</strong> atropine and pralidoxime, it should not be withheld even from children under 3 years old.Data source: Columbia University Mailman School <strong>of</strong> Public Health. Atropine use in children after nerve gas exposure. Info Brief.2004;1(1):1–8.Decontamination Equipment and Treatment SuppliesDecontamination equipment is another barrier toemergency management because it is not necessarilydesigned for use on children. High-pressure hoses andcold water used to decontaminate victims can exposechildren to significant risk, 45 resulting in hypothermiaand skin damage. Also, emergency care providers <strong>of</strong>tenneed to wear bulky, full-protective suits when treatingvictims, and these suits make it difficult to managesmall children requiring intricate procedures, such asblood draws.In addition to inappropriate decontaminationequipment, antidotes for chemical agents are not <strong>of</strong>tenavailable in ready-to-administer pediatric dosages. Inthe event <strong>of</strong> a chemical attack, pediatric healthcarecenters may be overwhelmed, and the ability to expandthe number <strong>of</strong> pediatric hospital beds may belimited. 32 Additionally, most healthcare workers arenot fully aware <strong>of</strong> the signs and symptoms <strong>of</strong> chemicalagent exposure. This problem is exacerbated becausechildren typically present differently than adults.For certain toxic agents, such as nerve agents, childrenpresent a clinical picture that can be very differentthan that observed in adults. For example, children incholinergic crisis may not necessarily manifest withmiosis (constriction <strong>of</strong> pupils). 33 One case series demonstratedthe absence <strong>of</strong> miosis in 43% <strong>of</strong> pediatricvictims. Studies involving pediatric exposure to OPshave suggested the appearance <strong>of</strong> isolated CNS effects(such as stupor and coma) in the absence <strong>of</strong> peripheralmuscarinic effects. Pediatric victims <strong>of</strong> OP intoxicationdisplay significant muscular weakness and hypotoniain the absence <strong>of</strong> glandular secretions in 70% to 100% <strong>of</strong>cases involving moderate to severe levels <strong>of</strong> exposure. 33<strong>The</strong> presentation <strong>of</strong> central intoxication (weakness andhypotonia) from OPs without peripheral muscarinicsigns and symptoms is atypical in adults.EFFECTS OF SPECIFIC AGENTS on a pediatric populationNerve AgentsNerve agent exposure can quickly incapacitate victimsand can lead to mortality if not recognized andtreated promptly (Exhibit 21-1). Nerve agent toxicitycan be enhanced in children because <strong>of</strong> their unique pediatricvulnerabilities, and it is important to recognizethe different ways children may present with toxicitycompared to adults.Nerve agents include tabun, sarin, cyclosarin,soman, and VX. <strong>The</strong>se agents are clear, colorless,tasteless, and in most cases, odorless. <strong>The</strong>y have beendemonstrated to penetrate clothing and skin and arehighly toxic (as little as 10 mg <strong>of</strong> VX on the skin isconsidered to be the median lethal dose in adults). 33 Inaddition, nerve agents produce toxicity rapidly comparedto biological agents. Most G-series nerve agents(sarin, designated “GB” by the North Atlantic TreatyOrganization [NATO]; cyclosarin, NATO designation“GF”; tabun, NATO designation “GA”; and soman,NATO designation “GD”) are highly volatile and canbe dispersed into aerosols and inhaled by victims.Nerve agents may also be disseminated in liquid form.Treatment for dermal exposure begins with rapid topicaldecontamination.Although military experience managing nerve agenttoxicity is limited, exposures to related chemicals,such as the OP class, occur commonly each year inthe United States (in 2000 there were approximately10,000 OP exposures across the country). 67 OPs, suchas malathion, are commonly used as pesticides, andtoxicity manifests similarly to nerve agent toxicity,661

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!